Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

US Patent 8034809 · Granted Oct 11, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline form of LNP0232025
Substituted triazolo quinoxaline derivatives2024
Crystalline forms of a TLR7/TLR8 inhibitor2024
Substituted pyrazole amides2024
Further substituted triazolo quinoxaline derivatives2024
Polymorphs2024
Crystalline form of LNP0232023
Solid forms of a GlyT1 inhibitor2022
Polymorphs2021
Further substituted triazolo quinoxaline derivatives2021
3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives2020
3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives2020